Dapsone in the treatment of Kaposi´s sarcoma
DOI:
https://doi.org/10.2340/0001555564561563Abstract
Previously we observed clinical and histological regression of Kaposi´s sarcoma in the skin in a 38-year-old man with AIDS following treatment with Dapsone. This observation initiated the present study where 6 patients with Kaposi´s sarcoma in the skin without clinical signs of systemic spreading were treated with Dapsone 100 mg daily for four months. During this treatment clinical and histological regression of Kaposi´s sarcoma was found in three patients. In a further patient only clinical regression was found, while no regression was found in the remaining two patients with Kaposi´s sarcoma.Downloads
Download data is not yet available.
Downloads
Published
1984-11-01
How to Cite
Poulsen, A., Hultberg, B., Thomsen, K., & Lange Wantzin, G. (1984). Dapsone in the treatment of Kaposi´s sarcoma. Acta Dermato-Venereologica, 64(6), 561–563. https://doi.org/10.2340/0001555564561563
Issue
Section
Articles
License
LicenseAll digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
